Azenta, Inc. (AZTA)
Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
Azenta Q3 Earnings Call Highlights
Azenta NASDAQ: AZTA reported third-quarter fiscal 2026 revenue that exceeded its outlook, as growth in recurring-revenue businesses and improved Multiomics performance helped offset continued unevenness in capital equipment markets.
Allspring Common Stock Fund: Q1 2026 Top Contributors And Detractors
Health care was the most significant detractor, led by weakness within life sciences tools and services, while consumer discretionary and IT also weighed on relative performance. Regal Rexnord Corp. performed strongly in the first quarter, primarily on account of a quarterly report that featured particularly strong orders owing to budding demand for data center products. Westlake Corp. outperformed in the first quarter due to the effects on global chemical markets from the conflict in Iran, which has had an extreme impact on supply.
Azenta: Life Science Player Fails To Come To Life
Azenta, Inc. trades near $20, with operating assets valued at just 0.5x sales and a robust net cash position around $600 million. Recent AZTA developments include the UK Biocentre acquisition and B Medical Systems divestiture, with the latter removing a key earnings drag. Despite a soft Q1 and margin pressure, Azenta maintains full-year guidance, supported by remediation efforts and interest income.
Azenta, Inc. (AZTA) M&A Call Transcript
Azenta, Inc. (AZTA) M&A Call Transcript
Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript
Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript
New Strong Sell Stocks for January 8th
AZTA, BCBP and CLCO have been added to the Zacks Rank #5 (Strong Sell) List on January 8th, 2026.
Azenta, Inc. (AZTA) Analyst/Investor Day Transcript
Azenta, Inc. (AZTA) Analyst/Investor Day Transcript
New Strong Sell Stocks for December 9th
BRBR, AZTA and BRDCY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2025.
Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript
Azenta, Inc. ( AZTA ) Q4 2025 Earnings Call November 21, 2025 8:30 AM EST Company Participants Yvonne Perron - Vice President of Financial Planning & Analysis and Investor Relations John P. Marotta - President, CEO & Director Lawrence Lin - Executive VP & CFO Conference Call Participants David Saxon - Needham & Company, LLC, Research Division Steven Etoch - Stephens Inc., Research Division Andrew Cooper - Raymond James & Associates, Inc., Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Jacqueline Kisa - TD Cowen, Research Division Paul Knight - KeyBanc Capital Markets Inc., Research Division Presentation Operator Greetings, and welcome to the Azenta Q4 2025 Financial Results.
Azenta, Inc. (AZTA) Q3 2025 Earnings Call Transcript
Azenta, Inc. (NASDAQ:AZTA ) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants John P. Marotta - President, CEO & Director Lawrence Y.
Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript
Azenta, Inc. (NASDAQ:AZTA ) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Yvonne Perron - Vice President, Financial Planning & Analysis and Investor Relations John Marotta - President and Chief Executive Officer Lawrence Lin - Chief Financial Officer Conference Call Participants David Saxon - Needham & Company, LLC Vijay Kumar - Evercore Inc. Paul Knight - KeyBanc Capital Markets Inc. Matthew Stanton - Jefferies Group LLC Brendan Smith - TD Cowen Operator Greetings, and welcome to the Azenta Q2 2025 Financial Results. During the presentation, all participants will be in a listen-only mode.
